Tom Miller Participates in NVIDIA Grand Challenge Panel During Spring GTC21
Presentations
This is some text inside of a div block.
April 1, 2021
.jpg)
Related announcements
Podcast Discusses New Advances for Iambic's Clinical Oncology Study and its AI-Driven Drug Discovery Platform
Podcast Discusses New Advances for Iambic's Clinical Oncology Study and its AI-Driven Drug Discovery Platform
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Iambic Therapeutics to Present New Pre-Clinical Data for IAM1363, a Selective and Brain-Penetrant Inhibitor of both HER2 Wild-Type and Oncogenic Mutants, at the 2024 AACR Annual Meeting